NSAID GI Safety To Go Under Advisory Panel's Endoscope
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Gastrointestinal Drugs Advisory Committee will discuss the criteria for a claim of preventing NSAID-triggered GI complications at a Nov. 4 meeting.